PLCγ contributes to metastasis of in situ-occurring mammary and prostate tumors
Authors:
- 20 November 2006
- journal article
- Published by Springer Nature in Oncogene
- Vol. 26 (21) , 3020-3026
Abstract
Phospholipase C- (PLC) has been implicated in tumor cell motility required for invasiveness and metastasis. Diminished tumor dissemination has been demonstrated in xenograft models, but studies in naturally-occurring tumors are lacking, having been limited by the timing of the interventions. Therefore, we generated mice that express a doxycycline (DOX)-inducible dominant-negative fragment of PLC, PLCz; this approach avoids the in utero lethality caused by the absence of PLC. As we targeted two de novo-occurring carcinomas of the mammary (MMTV-driven polyoma middle T antigen model, PyVmT) and prostate (TRAMP model) glands, we limited expression to these epithelial cells by driving DOX transactivator from the prostatein C3 promoter. This avoids the confounding variable of potentially abrogating motility in stromal and endothelial cells. These mice developed normally in the presence of DOX, except for limited mammary development if treated before 6 weeks and immaturity of the prostate gland if treated before 2 weeks of age. DOX-mediated induction of PLCz from age 8 to 16 weeks in PyVmT mice decreased the number of lung metastases by >10-fold (Pin situ tumor cell proliferation or tumor size. Lung metastases were also significantly decreased in the TRAMP model in which the mice expressed the PLCz fragment (P signaling pathway can limit the metastatic potential of carcinomas.Keywords
This publication has 31 references indexed in Scilit:
- IP-10 Blocks Vascular Endothelial Growth Factor-Induced Endothelial Cell Motility and Tube Formation via Inhibition of CalpainCirculation Research, 2006
- Phospholipase C and cofilin are required for carcinoma cell directionality in response to EGF stimulationJournal of Cell Biology, 2004
- Epidermal Growth Factor Induces Fibroblast Contractility and Motility via a Protein Kinase C δ-dependent PathwayJournal of Biological Chemistry, 2004
- Cell Migration: Integrating Signals from Front to BackScience, 2003
- Induction of cancer cell migration by epidermal growth factor is initiated by specific phosphorylation of tyrosine 1248 of c‐erbB‐2 receptor via epidermal growth factor receptorThe FASEB Journal, 2002
- The induction of uterine leiomyomas and mammary tumors in transgenic mice expressing polyomavirus (PyV) large T (LT) antigen is associated with the ability of PyV LT antigen to form specific complexes with retinoblastoma and CUTL1 family membersOncogene, 1998
- Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor αJournal of Cellular Physiology, 1996
- Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement.Journal of Cell Biology, 1994
- Regulation of chemotaxis by the platelet-derived growth factor receptor-βNature, 1994
- Functional characterization of an androgen response element in the first intron of the C3(1) gene of prostatic binding proteinBiochemical and Biophysical Research Communications, 1989